Insulin resistance, defined as the diminished responsiveness of insulin-target tissues to insulin, is the central pathogenic mechanism underlying obesity-associated disorders such as type 2 diabetes mellitus (T2DM), non-alcoholic fatty liver disease (NAFLD), and atherosclerosis [2,3]. Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.